Qoyvolma

ustekinumab · Celltrion Healthcare Hungary Kft.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Qoyvolma, covering 2026-04-16 to 2026-07-31. Get the full timeline:

Most recent: EMA Withdrawn: Qoyvolma (ustekinumab) — Celltrion Healthcare Hungary Kft.